image

The best stocks to buy since 1993

Latest issue now available

Calnex - Strong sales momentum continues

July 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CLX
  • Price:
  • 158.5p
Lack of space meant I omitted my update last month. The latest FY21 results show another very strong year of trading, with sales of £22m, pretax profit up 64% to £6.0m and adjusted eps of 5.2p.  Net cash grew to £15.4m building on the money raised at IPO and post the period end it acquired  iTrineg whose NE-ONE Network Emulation platform is used by customers who might be moving their applications and services into the Cloud to analyse and predict an application's performance by recreating real-world network test environments. It is a small deal at £2.5m - equivalent to 1.8x sales.Meanwhile, demand for Calnex’s own telecoms testing equipment remains strong. Overall, Calnex received orders from 233 customers in the year, up 34 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe